Chongqing Kanglle Pharmaceutical Co., Ltd

Licensed projects: Production and sales (limited to the company's own production of drugs): APIs (cilostazol, chloroquine phosphate, piperaquine phosphate, amodiaquine hydrochloride, hydroxychloroquine sulfate, tigecycline (for export only); production and sales: pharmaceutical intermediates; import and export of goods and technology. (Projects that require approval according to law can only be carried out after approval by relevant departments. The specific business projects are subject to the approval documents or licenses of relevant departments) General projects: technical services, technical development, technical consulting, technical exchanges, technology transfer, technology promotion (except for projects that require approval according to law, business activities can be carried out independently in accordance with the law with a business license)
Business Type Manufacturer
Location ChinaChongqingYubei
Year Established 1988-01-14
Total Employees 235
Total Annual Revenue -
Main Products 1H-tetrazolyl, 4-hydroxy-7-chloroquinoline, allopurinol, pyrimidine, sulfonamide, calcium hydroxide, chlorobenzene, salicylic acid, sodium salicylate, hydrochloric acid, sulfur, sulfuric acid, sulfuric acid, phosphoric acid, phosphoric acid, sodium benzoate, benzenesulfonyl chloride, phenolic resin, aldehyde resin, aripiprazole
Main Market -